Current Drug Therapy

Stefano Palomba  
Obstetrics and Gynecology Unit
Institute for Hospitalization and Care Scientific
Emilia
Italy

Back

Development and Optimization of Troxipide Floating Delivery for Treatment of Peptic Ulcer

Author(s): Swati C. Jagdale, Shraddha B. Kamble, Bhanudas S. Kuchekar, Aniruddha R. Chabukswar.

Abstract:

Purpose: The objective of the present work was to develop a site specific gastro-retentive floating tablet of Troxipide for the treatment of peptic ulcer. Troxipide is a novel anti-ulcer agent having an elimination half-life of 7.4 hrs and mainly absorbed from the gastrointestinal tract.

Methods: 32 factorial design was applied. Dependant variables were swelling index, hardness and % drug release. Pluronic acid F127 and HPMC K 15M were used as rate controlled polymer. Optimized formulations were evaluated for physical characteristics, buoyancy, buoyancy lag-time, drug content, in- vitro drug release, floating behavior and in-vivo X-ray study.

Results: Formulation H5 (20% Pluronic acid F127 and 78% HPMC K 15M) showed a floating lag time 60 ±2 sec with a desired controlled release profile over a period of 10 hrs. FTIR and DSC studies confirmed no chemical interactions. In-vivo X-ray study for optimized formulations showed gastro retention for 6 hrs.

Conclusion: Results demonstrate feasibility of development of gastroretentive floating tablet of Troxipide.

Keywords: Factorial, gastro-retentive, peptic ulcer, troxipide, variables.

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

VOLUME: 9
ISSUE: 2
Year: 2014
Page: [83 - 92]
Pages: 10
DOI: 10.2174/1574885508666131217003926
Price: $58